MiniMed Flex System Now Available to Medicare Beneficiaries in US

Key Facts

In a move reflecting the ongoing expansion in the health technology sector, MiniMed has announced that its MiniMed Flex system and latest sensor portfolio are now available to Medicare and Medicare Advantage beneficiaries. According to reports, this expansion aims to increase market access for the company's latest diabetes technology among the elderly and eligible populations in the United States. This announcement follows the company's strategy to broaden its user base through official reimbursement channels.

This expansion marks a significant milestone in strengthening the company's market share by opening access to a vast segment of government-insured beneficiaries. Based on the available data, providing these technologies to Medicare recipients represents a positive development in the company's growth trajectory, although it is considered a standard regulatory milestone in the healthcare industry. Diabetes tech firms continue to compete for insurance coverage to ensure wider product distribution.

Regarding broader economic catalysts, investors are looking ahead to the US Retail Sales and Initial Jobless Claims data scheduled for July 16, 2026, which may influence market sentiment across the healthcare sector and US equities.